Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases
- PMID: 24033287
- DOI: 10.1111/cge.12258
Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases
Abstract
The mode of inheritance of Alport syndrome (ATS) has long been controversial. In 1927, the disease was hypothesized as a dominant condition in which males were more severely affected than females. In 1990, it was considered an X-linked (XL) semidominant condition, due to COL4A5 mutations. Later on, a rare autosomal recessive (AR) form due to COL4A3/COL4A4 mutations was identified. An autosomal dominant (AD) form was testified more recently by the description of some large pedigrees but the real existence of this form is still questioned by many and its exact prevalence is unknown. The introduction of next generation sequencing (NGS) allowed us to perform an unbiased simultaneous COL4A3-COL4A4-COL4A5 analysis in 87 Italian families (273 individuals) with clinical suspicion of ATS. In 48 of them (55%), a mutation in one of the three genes was identified: the inheritance was XL semidominant in 65%, recessive in 4% and most interestingly AD in 31% (15 families). The AD form must therefore be seriously taken into account in all pedigrees with affected individuals in each generation. Furthermore, a high frequency of mutations (>50%) was shown in patients with only 1 or 2 clinical criteria, suggesting NGS as first-level analysis in cases with a clinical suspicion of ATS.
Keywords: Alport syndrome; COL4A3, COL4A4 and COL4A5 genes; autosomal dominant; molecular diagnosis; next generation sequencing.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.Kidney Int. 2002 Jun;61(6):1947-56. doi: 10.1046/j.1523-1755.2002.00379.x. Kidney Int. 2002. PMID: 12028435
-
Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.Kidney Int. 2004 May;65(5):1598-603. doi: 10.1111/j.1523-1755.2004.00560.x. Kidney Int. 2004. PMID: 15086897
-
Novel mutations of COL4A3, COL4A4, and COL4A5 genes in Chinese patients with Alport Syndrome using next generation sequence technique.Mol Genet Genomic Med. 2019 Jun;7(6):e653. doi: 10.1002/mgg3.653. Epub 2019 Apr 9. Mol Genet Genomic Med. 2019. PMID: 30968591 Free PMC article.
-
Digenic Alport Syndrome.Clin J Am Soc Nephrol. 2022 Nov;17(11):1697-1706. doi: 10.2215/CJN.03120322. Epub 2022 Jun 8. Clin J Am Soc Nephrol. 2022. PMID: 35675912 Free PMC article. Review.
-
Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members.Pediatr Nephrol. 2020 Jan;35(1):59-66. doi: 10.1007/s00467-018-4121-1. Epub 2018 Nov 30. Pediatr Nephrol. 2020. PMID: 30506145 Review.
Cited by
-
Self-Assembled Peptide-Based Biocomposites for Near-Infrared Light Triggered Drug Release to Tumor Cells.Biotechnol J. 2020 Dec;15(12):e2000128. doi: 10.1002/biot.202000128. Epub 2020 Sep 15. Biotechnol J. 2020. PMID: 32845561
-
Quantitative assessment of glomerular basement membrane collagen IV α chains in paraffin sections from patients with focal segmental glomerulosclerosis and Alport gene variants.Kidney Int. 2024 May;105(5):1049-1057. doi: 10.1016/j.kint.2024.01.036. Epub 2024 Feb 22. Kidney Int. 2024. PMID: 38401706
-
Kidney Disease Associated With Mono-allelic COL4A3 and COL4A4 Variants: A Case Series of 17 Families.Kidney Med. 2023 Feb 1;5(4):100607. doi: 10.1016/j.xkme.2023.100607. eCollection 2023 Apr. Kidney Med. 2023. PMID: 36925663 Free PMC article.
-
Renal transplantation in patients with Alport syndrome: patient selection, outcomes, and donor evaluation.Int J Nephrol Renovasc Dis. 2018 Oct 16;11:267-270. doi: 10.2147/IJNRD.S150539. eCollection 2018. Int J Nephrol Renovasc Dis. 2018. PMID: 30410383 Free PMC article. Review.
-
Guidelines for Genetic Testing and Management of Alport Syndrome.Clin J Am Soc Nephrol. 2022 Jan;17(1):143-154. doi: 10.2215/CJN.04230321. Epub 2021 Dec 20. Clin J Am Soc Nephrol. 2022. PMID: 34930753 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials